Dose: 0.357 to 2.5 mg/kg
Single Dose: 1.4 (1.4285)
Frequency: 24 hourly
Route: PO
Instructions: Initial

Dose: 1 mg/kg
Single Dose: 1 (1)
Frequency: 8 hourly
Route: Oral
Instructions: Initially for 3 days

Dose: 1 mg/kg
Single Dose: 1 (1)
Frequency: 8 hourly
Route: Oral
Instructions: Initially for 3 days

. It is of Synthetic origin and belongs to Piperazine. It belongs to Anthelmintics pharmacological group.The Molecular Weight of Diethylcarbamazine (Citrate) is 391.40. Its pKa is 7.7.

Diethylcarbamazine (Citrate) is contraindicated in conditions like Hypersensitivity to murine proteins.

Diethylcarbamazine (Citrate) produces potentially life-threatening effects which include Conjunctivitis, Visual field loss, Encephalitis, Retinal hemorrhage, Mazzotti Reaction, Iridocyclitis. which are responsible for the discontinuation of Diethylcarbamazine (Citrate) therapy.The signs and symptoms that are produced after the acute overdosage of Diethylcarbamazine (Citrate) include Nausea, Vomiting, Drowsiness, Dizziness.The symptomatic adverse reactions produced by Diethylcarbamazine (Citrate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Drowsiness, Nausea, Fever, Chills, dizziness.

Diethylcarbamazine (Citrate) is primarily indicated in conditions like Filarial infection, Lymphatic filariasis, Onchoceriasis.

Diethylcarbamazine (Citrate) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAcetazolamide (Na)Acetazolamide reduce urinary excretion and enhance pharmacological effect These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Liver Malfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store in a well closed container, at room temperature.

Diethylcarbamazine should be used with caution in patients with renal impairment. Avoid use in infants, pregnant women, elderly or debiliated, especially in those with cardiac or renal disease. and in hyper sensitive pateints.